The five-year OS probability was 42.6% (95% CI 28.49-56.71) and 51.2% (95% CI 35.92-66.48), respectively, for p16-negative and p16-positive tumours, p=0.689 (Figure 1). The gene discussed is CDKN2A; the disease is neoplasm.